Illest, I think you are right about how big the Tommy Chong

New Post Public Reply Private Reply Replies (1) Message Board
EliteYoda The Illest #9071

Illest, I think you are right about how big the Tommy Chong endorsement is for the product. I think you are right about the fact that this is a brilliant, innovative product entering the market at the perfect time and that the potential consumer base for this product is HUGE! However, I will disagree on what I think is the primary factor in limiting sales, and/or "standing in our way". I do not think its production rates or manufacturing at all. I think given the money, the company could order millions of units and China would churn them out quickly with no problem. I personally think that the main limiting factor for rate of sales is basically exposure in the industry and marketing. If tomorrow there were TV commercials on MTV, Spike, etc and the major news channels as well as radio and internet (ad) marketing campaigns running non-stop, all day, every day, directing consumers to the website, I happen to believe that the web traffic would be off the charts insane. I think in such a scenario, the demand could quickly outpace the supply and the corp would need more units and be making money hand over fist. Of course though it takes money to make money and with marketing campaigns, it costs a lot to get overall exposure. TV commercials and radio are insanely expensive and even online ad marketing has become pricey. I think Cheryl's level of celebrity exposure is a HUGE plus for the product on the marketing side, but even celebrity exposure takes time for the market of consumers to digest and begin to learn about the product and eventually desire to have one. I think the primary limiting factor is marketing and the amount of money needed to engage a large overall marketing campaign to draw in consumers in order to make massive sales. RFMK is named Rapid Fire MARKETING though so I am hopeful there is a good marketing plan for the future. I think with the monthly funding from Ironridge, RFMK has a very good chance to get a good marketing campaign going.

As for the product, IMO, hands down, it is THE best (quality and price) in the market right now.

GLTY

$RFMK

Rapid Fire Marketing, Inc. (RFMK) Stock Research Links

RFMK Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Perrigo's Reinvention Strategy: A Path to Sustainable Success

Updated Category News Views 152

Perrigo Restructures for Future Growth and Performance Perrigo Company plc (NYSE: PRGO), a recognized leader in the consumer self-care products industry, has embarked on an ambitious path of organizational realignment aimed at ensuring sustainable growth and enhanced operational performance. This strategic initiative is expected to bolster agility and innovation within...

Continue Reading
Eli Lilly Prepares for Weight-Loss Drug Launch Amid FDA Review

Updated Category News Views 225

Eli Lilly's Strategic Inventory Build-Up Eli Lilly and Company (NYSE: LLY) has made headlines recently by accumulating an impressive $1.5 billion worth of inventory for its experimental oral weight-loss pill, orforglipron. This move comes in light of the anticipated decision by the FDA, which could take place in the near future. The increase in inventory value represents...

Continue Reading
Roblox's CFO Transition: Leadership Change and Future Prospects

Updated Category News Views 352

Roblox Corporation Announces CFO Transition Roblox Corporation (NYSE:RBLX) has recently made headlines as its Chief Financial Officer, Michael Guthrie, prepares to leave his post to focus on personal pursuits. This change reflects a significant moment in the company's leadership dynamics, with the announcement stemming from a formal Separation and Transition Agreement....

Continue Reading
MaxCyte's 2024 Financial Results Highlight Growth and Innovation

Updated Category News Views 149

MaxCyte Reports Positive Financial Results for 2024 MaxCyte, Inc. (NASDAQ: MXCT; LSE: MXCT), a renowned company at the forefront of cell engineering, has shared exciting preliminary financial outcomes for its fourth quarter and the entire year of 2024. These results demonstrate steady growth in revenue and a stronger position in the rapidly evolving cell therapy industry....

Continue Reading
XORTX Therapeutics Invites Shareholders to Participate Actively

Updated Category News Views 113

XORTX Therapeutics Encourages Shareholder Participation CALGARY, Alberta – XORTX Therapeutics Inc. (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a leading clinical pharmaceutical company focused on developing innovative therapies for progressive kidney disease, is reaching out to its shareholders. They want to remind everyone about the important voting deadline for the...

Continue Reading